BP
Blueprint Medicines
BPMC·NASDAQCambridge MAFounded 20111,000 employees
Mid CapbiotechPublicOncologyHematologyRare Disease
Platform: Kinase Inh
Market Cap
$7B
All Drugs
4
Clinical Trials
5
Failed / Terminated
3
FDA Approved
0
Stock Price & Catalysts (BPMC)
Loading BPMC stock data...
Drug Pipeline (4 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Bemanaritide | BPM-1126 | Phase 2 | 1 | CD38 | Dravet | ||
| Suracapivasertib | BPM-9580 | Preclinical | 1 | PRMT5 | LGS | ||
| Mavuratamab | BPM-2504 | NDA/BLA | 1 | BET | PAHHuntington's | ||
| Talafotisoran | BPM-3073 | Phase 2/3 | 2 | IL-23 | GA |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (5)